Aortic valve replacement with the University of Cape Town lenticular prosthesis was performed in 149 patients during a six-year period, almost all patients being severely disabled with advanced heart disease.
It is six years since the University of Cape Town aortic lenticular prosthesis was introduced clinically. The basic design has been previously described (Barnard, Schrire, and Goosen, I963) and the early results reported (Schrire et al., I967) . The prosthesis has been shown to function adequately from the haemodynamic point of view (Beck, Barnard, and Schrire, I966) in that it is completely competent and a good cardiac output can be maintained at the expense of a tolerably small gradient across the prosthesis. In this respect it compares favourably with other prosthetic designs in current use (Morrow et al., I964; Judson et al., I964; Bristow et al., I964) .
Significant problems have been postoperative systemic embolism, which has however been far less than with the mitral prosthesis (Schrire and Barnard, I970) , and Received I5 August 1969. sudden death. Two major changes in design resulted in three series of patients whose progress can be compared. The reduction in incidence of the two major complications mentioned above has been associated with some new complications but these have been relatively insignificant.
Subjects and methods
Between March i963 and October i968, aortic valve replacement was performed in I49 patients (Table i) . Since then a further 30 patients have been operated upon, but these will be excluded because a six-month follow-up period is not yet available. There were 114 male and 35 female patients; the age distribution ranged from I2 to 65, with more than half between 30 and 59, the average age being 45. Patients in whom both aortic and mitral valve replacement was performed have been excluded from this analysis but not the two patients in whom a palliative mitral valve procedure only was done. Sixty-seven patients had aortic incompetence, 58 aortic stenosis, and 24 stenosis and incompetence. Syphilis was the cause in eight, congenital heart disease in I3, and aortic dilatation (one with frank Marfan's syndrome) in five. Rheumatic fever was assumed to be the cause in the remainder, though a past history of rheumatic fever or associated valve lesions were present in less than two-thirds. One patient had severe pulmonary valve stenosis with aortic incompetence, and a pulmonary valvotomy was performed at the same time as the aortic valve replacement. One patient had a sinus of Valsalva aneurysm which had burrowed into the heart. One patient had a large coexistent ventricular septal defect repaired. One patient had previously been operated upon for aortic coarctation. Antecedent bacterial endocarditis was a particularly dangerous event precipitating severe heart failure in 20 patients, and two of these were operated upon while active disease was still present, though they had been clinically 'cured' for six months. Cases of calcific stenosis of congenital origin may have been called rheumatic in the absence of a history of a murmur dating from childhood.
Initially, when the procedure was on trial, it was reserved for the severely disabled and often terminal patients, but when the results were found to be so rewarding and improvement was sustained over several years without any valve wear, operation was advised in patients with grade 2 disability (New York Heart Association classification), and, rarely, for patients in grade i with severe haemodynamic abnormality. The indications for operation were almost always apparent on the basis of the symptoms and clinical examination (Schrire, I966) . As shown in Table I , there were 59 patients in grade 4, 74 in grade 3, 14 in grade 2, and two in grade I.
Pre-operative cardiac catheterization and angiocardiographic studies were made in 62 of the first 74 patients. Thereafter investigation was only performed in cases of doubt or under special circumstances (26 patients). Operation for aortic stenosis was never undertaken unless the peak gradient across the aortic valve was at least 5o mm. Hg, except in a few patients with particularly low cardiac outputs. Operation was not refused on the grounds of advanced heart failure or age; the oldest patient successfully operated to date being 73. Intractable heart failure despite adequate medical therapy was no bar, and strenuous efforts to remove all oedema before operation were not made. Changes in valve design The operative management has been described elsewhere (Barnard et al., I963; Schrire et al., I967) .
The valve consists of two components, one of which is secured in the aortic root and the other freely mobile (Fig. i) . The fixed portion is made from a single piece of stainless steel. It has a ring forming the seat of the mobile unit to which a rim of plastic material is attached to permit the valve to be sutured in the subcoronary position. In addition, the steel ring carries two polished stainless steel arms, the one above projecting into the aorta and the one below in the left ventri- 
Results
Beneficial results of operation One hundred and thirty-one patients were discharged from hospital, and in these cardiovascular function was remarkably improved as shown in Table 2 . Syncope, effort dyspnoea, paroxysmal dyspnoea, pulmonary oedema, congestive failure, and even angina pectoris Total 149 i8 12 disappeared in almost every patient, and generally all cardiac therapy could be discontinued soon after discharge from hospital. Return to full normal activity including physical work was the rule.. Eighty-nine of the patients were asymptomatic six months after operation and, with eight exceptions, remained so throughout the period of observation. Radiological improvement was noted particularly in patients with aortic incompetence in whom considerable reduction in heart size occurred.
Hospital mortality Eighteen patients (I2%) died without leaving hospital (Table  3) . Fourteen died in the immediate postoperative period or within a few days or more after operation, usually from uncontrolled arrhythmias. Initial experience indicated that particular attention must be paid to potassium administration in the immediate post-operative period, especially in patients with aortic incompetence. In at least two patients (one not included in this series), however, cardiac infarction directly attributable to the perfusion procedure was shown at necropsy to be responsible. Four patients died later; three from bacterial endocarditis, and one from cerebral haemorrhage associated with anticoagulant therapy. Two of the three patients who died from endocarditis were operated upon six months after apparent cure of staphylococcal endocarditis, but active endocarditis was found at the time of operation in both; one contracted candida endocarditis and died from the results of this infection on the prosthetic valve.
Long-term mortality Twenty-eight of the 131 patients who left hospital alive died later from cardiovascular disease (Table 4) Long-term complications Aortic incompetence, haemolytic anaemia, systemic embolism, and angina were the main longterm complications.
Aortic incompetence An early diastolic murmur was uncommon post-operatively with the first two types of valve (7 patients) but has occurred in onethird of the patients in whom the Dacronvelour cloth-covered valve was used. This was purely an auscultatory finding with no haemodynamic effects and with no progression, except in four patients. It could usually be heard shortly after the operation. In two, 
Haemolytic anaemia
Haemolytic anaemia was only encountered in the cloth-covered valve. In one this was transient and settled after a few months. One symptom-free patient ran a persistent mild chronic anaemia. In our total series of I04 patients with cloth-covered valves, haemolysis has been present in four, in two of whom aortic incompetence has been associated.
Systemic embolism
How many sudden deaths could be attributed to embolism could not be determined, but a certain proportion undoubtedly were, and this constitutes a serious problem. Unlike the mitral valve prosthesis, however, serious neurological episodes were exceptional. Emboli were presumably small platelet fibrin thrombi producing transient focal symptoms such as dysphasia, numbness of a limb, or hemiplegia lasting from an hour or two to a few days, and leaving no residua. The following factors were shown to have no bearing on these complications: the nature of the pre-existing lesion, the haemodynamic status before operation (pulmonary vascular resistance, pulmonary artery pressure, pulmonary wedge or left atrial pressure, the aortic valve gradient or degree of incompetence, and the cardiac index), the age of the patient, the size of the heart, the disability before operation, the presence or absence of angina pectoris and the state of the electrocardiogram, including the presence or absence of left axis deviation.
The difficulties of assessing the effects of long-term anticoagulant therapy have been discussed elsewhere (Schrire and Barnard, FIG. 2 Long-term follow-up of patients with Type I prosthesis. The Type i valve was inserted into 37 patients (I-37 on the ordinate), all but the last two between March I963 andJuly I965.
Duration offollow-up is shown in months on the abscissa. In this and the succeeding two figures, emboli are shown as transverse lines, the width of which denotes the severity. Cross-hatching refers to severe neurological deficit. L TA = long-term anticoagulants, CCF = congestive cardiac failure, SBE or ABE= subacute or acute bacterial endocarditis, t = death, CT= cardiac infarction and x -hatched cubes = sudden death. Systemic emboli manifesting with one exception as cerebral episodes occurred in 7 patients and sudden death in 3. In Case 28 the valve was replaced because of valve thrombosis. I970). On the whole, our experience has been unfavourable. One patient died of cerebral haemorrhage in hospital, and three had gastro-intestinal haemorrhages, one in the immediate post-operative period and two 22 and 40 months after operation, respectively. For one reason or another several of our patients with a Type 3 valve failed to continue with this therapy and showed no untoward effect. In our last 63 patients we have stopped anticoagulants three months after operation and the only patient who suffered systemic embolism (and later died) was in fact on anticoagulants at the time.
The most important factor appeared to be the type of prosthesis used. With the Type i valve, small emboli manifesting as transient cerebral episodes occurred in seven patients   FIG. 4 Long-term follow-up of patients with Type 3 prosthesis. The Type 3 valve was inserted into 75 patients between November I966 and October 1968. Sudden death occurred in three patients. Case 6, dying suddenly 20 months after operation, sustained severe cerebral damage from air embolism at the time of operation, and Case 48 developed a hemiplegia after operation. Case 52 developed complete heart block after operation and required insertion of a permanent pacemaker; Case 68 had complete heart block before operation. Only one patient had a transient hemiplegia presumably due to a small embolus. Key as for Fig. 2 . Results of aortic valve replacement 26I (Fig. 2) but produced significant residual neurological disability in only one. Sudden death occurred in three patients and in one thrombosis of the valve occurred requiring replacement. With the Type 2 valve, there was an immediate increase in sudden death to ii, with embolic episodes in six (Fig. 3) . With the Type 3 valve, there was an immediate reduction in incidence of sudden deaths to three patients (Fig. 4) (Beck et al., 1966) . The valve was shown to be moderately stenotic without significant incompetence, and in only one of these patients was persistent left ventricular failure observed; whether this was due to intimal sclerosis of the muscular coronary arteries as described by Barratt-Boyes (I964), altered flow patterns past the coronary ostia caused by the mobile portion of the valve, irreversible myocardial damage, the result of longstanding aortic valve disease, coronary emboli, or myocardial damage sustained during cardiac bypass and coronary perfusion, was not known. This is an unusual result, however, and was noted in only seven subsequent patients.
Radiological assessment of cardiac function was studied in 25 patients (Gotsman et al., I968) one year after operation, attention being paid to heart volume, cardiothoracic ratio, individual chamber enlargement, aortic and pulmonary arterial enlargement, and the pulmonary vascular pattern. In i5 patients heart volume and cardiothoracic ratio had returned to normal, the greatest improvement being observed in patients with aortic incompetence. Failure to return to normal was due to associated mitral valve disease, persistent aortic incompetence, or myocardial disease due either to coronary artery disease or to some form of cardiomyopathy. Pulmonary venous hypertension was present in nearly all patients before operation but persisted in only nine. There was little improvement in the size or configuration of the aorta. The major problems have been the occurrence of sudden death and systemic embolism, and the most important factor responsible for these complications has been the design of the valve (Fig. 5 ). Valves with a bare steel seat were associated with the highest incidence of sudden death, and systemic embolism was also common. A cloth-covered valve has almost eliminated systemic embolism, but sudden death does still occur in these cases occasionally. The evidence regarding the effect of long-term anticoagulant therapy is equivocal, and we now believe that patients with a Dacron-velour clothcovered valve do not require long-term anticoagulant therapy. Whether they need any anticoagulant therapy at all has not yet been determined.
Aortic valve disease has been a well- (Effler, I964) . It is extremely rare after homograft replacement of the aortic valve but has been reported by Davies et al. (I968) and by Barratt-Boyes (I964). The grossly hypertrophied, often fibrosed, heart may well be vulnerable to electrical instability, and Barratt-Boyes in fact claimed to have shown small vessel disease. Irreversible heart disease may well be present at the time of operation, and this we have encountered in several of our patients.
Nothing worth while in life is obtained cheaply. The introduction of a cloth-covered valve has brought with it certain acceptable risks. Ball wear in the aortic position has not resulted in incompetence as in the mitral valve position (Schrire and Barnard, 1970) . However, haemolytic anaemia is a definite problem and has occurred in four of I04 patients to date; fortunately it has been either self-limiting or readily within the patient's compensatory ability.
